Under the terms of the merger agreement, at closing, Synergy will issue, and Callisto stockholders will receive, in a tax-free exchange, shares of Synergy common stock such that Callisto stockholders will own approximately 38.3 percent of the combined company on a pro forma basis and Synergy stockholders will own approximately 61.7 percent. In addition, the shares of common stock of Synergy issued to the Callisto stockholders will be subject to a lockup beginning on the effective date of the merger and ending on the earlier of (i) eighteen (18) months after such date or (ii) a Change in Control (as defined in the merger agreement). Under the terms of the merger agreement, each outstanding share of Callisto common stock will be exchanged for 0.17 shares of Synergy common stock and the 22,295,000 shares of Synergy held by Callisto will be canceled. (OTCBB:CLSP) announced today that they have entered into a definitive merger agreement pursuant to which Callisto will merge into Synergy. (Nasdaq:SGYP) and Callisto Pharmaceuticals, Inc. Synergy Pharmaceuticals has appointed Marino Garcia to the newly-created role of senior VP, corporate development.NEW YORK, J(GLOBE NEWSWIRE) - Synergy Pharmaceuticals Inc. He has experience in gastrointestinal market at Aptalis. Marino Garcia joins Synergy Pharmaceuticals Synergy Vision’s Corinne Whitehead (pictured below) will soon lead its Asia-Pacific offering, becoming the agency’s Head of Asia Synergy Studio complements Synergy’s scientific offering by contributing creative and smart solutions to clients.Ĭhanges at Oxford PharmaGenesis, Synergy Vision and akt health communicationsĬorrine Whitehead heads up Synergy Vision’s Asia-Pacific offering. Healthcare communs agency Synergy welcomes a new graphic designer to its growing studio. She brings over 20 years’ medical writing experience to the position, most recently working at Pro Pharma Communications. Hensler has previously worked with pharma brands across multiple channels, and has a particular focus on scientific excellence. New faces at Synergy Vision, Makara Health and JPA Health During her time at Synergy, Gallagher (pictured left) has worked as both a director and managing director. Gallagher has worked at Synergy Vision since its inception, having been part of the founding team. New executive appointments at Synergy Vision Ffyona Dawber, Synergy Vision’s managing director, said: “We realise that our team is Synergy Synergy was first awarded Core IIP accreditation back in 2011, which was upgraded to silver in 2013 and now the group has acquired gold status. Synergy Vision wins gold Investors in People accreditation.The Worthing office will primarily work with the London-based team to support the creation and execution of projects for Synergy’s chief executive Ffyona Dawber, said:īecoming the fourth office opening for the agency, Synergy Vision has other bases in in Dublin Ireland, and Sydney, Australia. Synergy will also explore reducing the use of freelancers to encourage flexible working initiatives for its employees, which it hopes will counteract the industry-wide low staff retention levels. Synergy Vision to introduce four-day working week.Josh Prince, Chief Marketing Officer at Omnicom Health Group said: “We are pleased to be welcoming Synergy Worldwide to Synergy Worldwide is a healthcare communications and medical education agency, with its global headquarters based in London, UK.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |